FDA Approves Pfizer’s Vaccine for Meningococcal Disease

FDA Approves Pfizer’s Vaccine for Meningococcal Disease The U.S. Food and Drug Administration has approved Pfizer’s application for Penbraya, a vaccine for people 10 through 25 that will offer protection against the five main kinds of bacteria that cause meningitis and blood poisoning.

Visit Direct Link

You Might Also Like

Post comment